Paper Agent · Headache and migraine
A prospective real-world analysis of erenumab in refractory chronic migraine.
Giorgio Lambru; Bethany Hill; Madeleine Murphy; Ivona Tylova; Anna P Andreou
Originally published in The journal of headache and pain · 2020-06-01
